JPWO2020178739A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020178739A5
JPWO2020178739A5 JP2021552600A JP2021552600A JPWO2020178739A5 JP WO2020178739 A5 JPWO2020178739 A5 JP WO2020178739A5 JP 2021552600 A JP2021552600 A JP 2021552600A JP 2021552600 A JP2021552600 A JP 2021552600A JP WO2020178739 A5 JPWO2020178739 A5 JP WO2020178739A5
Authority
JP
Japan
Prior art keywords
amino acid
eso
tcr
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021552600A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523554A5 (https=
JP2022523554A (ja
JP7561133B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051808 external-priority patent/WO2020178739A1/en
Publication of JP2022523554A publication Critical patent/JP2022523554A/ja
Publication of JP2022523554A5 publication Critical patent/JP2022523554A5/ja
Publication of JPWO2020178739A5 publication Critical patent/JPWO2020178739A5/ja
Priority to JP2024163997A priority Critical patent/JP2025000725A/ja
Application granted granted Critical
Publication of JP7561133B2 publication Critical patent/JP7561133B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552600A 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法 Active JP7561133B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024163997A JP2025000725A (ja) 2019-03-04 2024-09-20 Ｔ細胞受容体及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813642P 2019-03-04 2019-03-04
US62/813,642 2019-03-04
PCT/IB2020/051808 WO2020178739A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024163997A Division JP2025000725A (ja) 2019-03-04 2024-09-20 Ｔ細胞受容体及びその使用方法

Publications (4)

Publication Number Publication Date
JP2022523554A JP2022523554A (ja) 2022-04-25
JP2022523554A5 JP2022523554A5 (https=) 2023-03-13
JPWO2020178739A5 true JPWO2020178739A5 (https=) 2023-03-13
JP7561133B2 JP7561133B2 (ja) 2024-10-03

Family

ID=72337709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021552600A Active JP7561133B2 (ja) 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法
JP2024163997A Pending JP2025000725A (ja) 2019-03-04 2024-09-20 Ｔ細胞受容体及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024163997A Pending JP2025000725A (ja) 2019-03-04 2024-09-20 Ｔ細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220152104A1 (https=)
EP (1) EP3935174A4 (https=)
JP (2) JP7561133B2 (https=)
KR (1) KR20210149050A (https=)
CN (1) CN113906141B (https=)
AU (1) AU2020231927A1 (https=)
BR (1) BR112021017464A2 (https=)
CA (1) CA3132238A1 (https=)
IL (1) IL286037A (https=)
MX (1) MX2021010543A (https=)
SG (1) SG11202109589VA (https=)
TW (1) TWI872051B (https=)
WO (1) WO2020178739A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020231927A1 (en) * 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク Ｔ細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法
CA3233809A1 (en) * 2021-10-06 2023-04-13 University Health Network Modified immune cells and methods of use thereof
AU2024269870A1 (en) * 2023-05-05 2025-11-20 Board Of Regents, The University Of Texas System Multi-receptor natural killer cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2014207708A2 (en) * 2013-06-28 2014-12-31 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
KR101503341B1 (ko) * 2014-03-12 2015-03-18 국립암센터 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
WO2017076308A1 (zh) * 2015-11-04 2017-05-11 广州市香雪制药股份有限公司 识别ny-eso-1抗原短肽的tcr
WO2017120428A2 (en) * 2016-01-06 2017-07-13 Health Research, Inc. Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
AU2020231927A1 (en) * 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2022109953A5 (https=)
JP2020509767A5 (https=)
Spear et al. Strategies to genetically engineer T cells for cancer immunotherapy
US11052138B2 (en) Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
CN109694854B (zh) 通用型嵌合抗原受体t细胞制备技术
JP2021522820A5 (https=)
Shilyansky et al. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
CN112088008A (zh) 修饰细胞的扩增及其用途
Tsang et al. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
JP2019519245A5 (https=)
EP3240805A1 (en) Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
CN114616337A (zh) 嵌合CD3融合蛋白与基于anti-CD3的双特异性T细胞激活元件的联合表达
JP2020533962A5 (https=)
JP2021512637A5 (https=)
WO2022099076A1 (en) Cells comprising t cell-antigen couplers and uses thereof
JPWO2020193767A5 (https=)
JPWO2020194195A5 (https=)
JPWO2020048995A5 (https=)
JPWO2020178739A5 (https=)
JPWO2020178738A5 (https=)
JPWO2020178742A5 (https=)
CN113785064B (zh) T细胞受体及其使用方法
JPWO2020178740A5 (https=)
JPWO2020178741A5 (https=)
JPWO2020178743A5 (https=)